JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Acute lymphoblastic leukemia; B cell precursor leukemia
Established from the bone marrow of a 32-year-old woman with acute lymphoblastic leukemia (ALL L2) in first relapse
Homo sapiens Tissue:Bone marrow Morphology:Lymphoblast Properties: Suspension; single, relatively small, round cells Cytogenic data: human hyperdiploid karyotype - 47/48< 2n> X/XX, +8, +18, t(4; 11)(q21; q23), i(7q) - sideline without +8/18 - carries MLL-AFF1 (MLL-AF4) fusion gene - resembles published karyotype Patient: Female, Caucasian, 32 yrs of age Medium: RPMI-1640 Medium + 10% FBS Subculture: Cultures can be maintained by the addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at 0.5 X 10^6 viable cells/mL. Split saturated culture 1:3 to 1:4 every 3-4 days; Maximal density of about 4.0 x 10^6 cells/ml; 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X; CSF1PO: 11, 12; D13S317: 11; D16S539: 11, 12; D5S818: 12, 13; D7S820: 8, 12; THO1: 6, 9.3; TPOX: 8; vWA: 14, 17
Bone marrow Morphology:Lymphoblast Properties: Suspension; single, relatively small, round cells Cytogenic data: human hyperdiploid karyotype - 47/48< 2n> X/XX, +8, +18, t(4; 11)(q21; q23), i(7q) - sideline without +8/18 - carries MLL-AFF1 (MLL-AF4) fusion gene - resembles published karyotype Patient: Female, Caucasian, 32 yrs of age Medium: RPMI-1640 Medium + 10% FBS Subculture: Cultures can be maintained by the addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at 0.5 X 10^6 viable cells/mL. Split saturated culture 1:3 to 1:4 every 3-4 days; Maximal density of about 4.0 x 10^6 cells/ml; 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X; CSF1PO: 11, 12; D13S317: 11; D16S539: 11, 12; D5S818: 12, 13; D7S820: 8, 12; THO1: 6, 9.3; TPOX: 8; vWA: 14, 17
Lymphoblast Properties: Suspension; single, relatively small, round cells Cytogenic data: human hyperdiploid karyotype - 47/48< 2n> X/XX, +8, +18, t(4; 11)(q21; q23), i(7q) - sideline without +8/18 - carries MLL-AFF1 (MLL-AF4) fusion gene - resembles published karyotype Patient: Female, Caucasian, 32 yrs of age Medium: RPMI-1640 Medium + 10% FBS Subculture: Cultures can be maintained by the addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at 0.5 X 10^6 viable cells/mL. Split saturated culture 1:3 to 1:4 every 3-4 days; Maximal density of about 4.0 x 10^6 cells/ml; 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X; CSF1PO: 11, 12; D13S317: 11; D16S539: 11, 12; D5S818: 12, 13; D7S820: 8, 12; THO1: 6, 9.3; TPOX: 8; vWA: 14, 17
Suspension; single, relatively small, round cells Cytogenic data: human hyperdiploid karyotype - 47/48< 2n> X/XX, +8, +18, t(4; 11)(q21; q23), i(7q) - sideline without +8/18 - carries MLL-AFF1 (MLL-AF4) fusion gene - resembles published karyotype Patient: Female, Caucasian, 32 yrs of age Medium: RPMI-1640 Medium + 10% FBS Subculture: Cultures can be maintained by the addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at 0.5 X 10^6 viable cells/mL. Split saturated culture 1:3 to 1:4 every 3-4 days; Maximal density of about 4.0 x 10^6 cells/ml; 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X; CSF1PO: 11, 12; D13S317: 11; D16S539: 11, 12; D5S818: 12, 13; D7S820: 8, 12; THO1: 6, 9.3; TPOX: 8; vWA: 14, 17
human hyperdiploid karyotype - 47/48< 2n> X/XX, +8, +18, t(4; 11)(q21; q23), i(7q) - sideline without +8/18 - carries MLL-AFF1 (MLL-AF4) fusion gene - resembles published karyotype Patient: Female, Caucasian, 32 yrs of age Medium: RPMI-1640 Medium + 10% FBS Subculture: Cultures can be maintained by the addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at 0.5 X 10^6 viable cells/mL. Split saturated culture 1:3 to 1:4 every 3-4 days; Maximal density of about 4.0 x 10^6 cells/ml; 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X; CSF1PO: 11, 12; D13S317: 11; D16S539: 11, 12; D5S818: 12, 13; D7S820: 8, 12; THO1: 6, 9.3; TPOX: 8; vWA: 14, 17
Female, Caucasian, 32 yrs of age Medium: RPMI-1640 Medium + 10% FBS Subculture: Cultures can be maintained by the addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at 0.5 X 10^6 viable cells/mL. Split saturated culture 1:3 to 1:4 every 3-4 days; Maximal density of about 4.0 x 10^6 cells/ml; 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X; CSF1PO: 11, 12; D13S317: 11; D16S539: 11, 12; D5S818: 12, 13; D7S820: 8, 12; THO1: 6, 9.3; TPOX: 8; vWA: 14, 17
RPMI-1640 Medium + 10% FBS Subculture: Cultures can be maintained by the addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at 0.5 X 10^6 viable cells/mL. Split saturated culture 1:3 to 1:4 every 3-4 days; Maximal density of about 4.0 x 10^6 cells/ml; 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X; CSF1PO: 11, 12; D13S317: 11; D16S539: 11, 12; D5S818: 12, 13; D7S820: 8, 12; THO1: 6, 9.3; TPOX: 8; vWA: 14, 17
Cultures can be maintained by the addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at 0.5 X 10^6 viable cells/mL. Split saturated culture 1:3 to 1:4 every 3-4 days; Maximal density of about 4.0 x 10^6 cells/ml; 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X; CSF1PO: 11, 12; D13S317: 11; D16S539: 11, 12; D5S818: 12, 13; D7S820: 8, 12; THO1: 6, 9.3; TPOX: 8; vWA: 14, 17
Complete culture medium supplemented with 5% (v/v) DMSO
I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X; CSF1PO: 11, 12; D13S317: 11; D16S539: 11, 12; D5S818: 12, 13; D7S820: 8, 12; THO1: 6, 9.3; TPOX: 8; vWA: 14, 17
Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X; CSF1PO: 11, 12; D13S317: 11; D16S539: 11, 12; D5S818: 12, 13; D7S820: 8, 12; THO1: 6, 9.3; TPOX: 8; vWA: 14, 17
Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X; CSF1PO: 11, 12; D13S317: 11; D16S539: 11, 12; D5S818: 12, 13; D7S820: 8, 12; THO1: 6, 9.3; TPOX: 8; vWA: 14, 17
Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X; CSF1PO: 11, 12; D13S317: 11; D16S539: 11, 12; D5S818: 12, 13; D7S820: 8, 12; THO1: 6, 9.3; TPOX: 8; vWA: 14, 17
HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X; CSF1PO: 11, 12; D13S317: 11; D16S539: 11, 12; D5S818: 12, 13; D7S820: 8, 12; THO1: 6, 9.3; TPOX: 8; vWA: 14, 17
Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X; CSF1PO: 11, 12; D13S317: 11; D16S539: 11, 12; D5S818: 12, 13; D7S820: 8, 12; THO1: 6, 9.3; TPOX: 8; vWA: 14, 17
Hepatitis C: Negative DNA Profile (STR): Amelogenin: X; CSF1PO: 11, 12; D13S317: 11; D16S539: 11, 12; D5S818: 12, 13; D7S820: 8, 12; THO1: 6, 9.3; TPOX: 8; vWA: 14, 17
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!